Group One Trading
LFCR icon

Group One Trading’s Lifecore Biomedical LFCR Stock Holding History

Group One Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2K Sell
10,000
-1,500
-13% -$10.4K ﹤0.01% 5494
2025
Q4 		$94.1K Buy
11,500
+11,200
+3,733% +$82.9K ﹤0.01% 5055
2025
Q3 		$2.21K Sell
300
-5,900
-95% -$44.6K ﹤0.01% 7869
2025
Q2 		$50.3K Buy
6,200
+5,400
+675% +$36.4K ﹤0.01% 5566
2025
Q1 		$5.63K Sell
800
-14,700
-95% -$91.4K ﹤0.01% 6590
2024
Q4 		$115K Buy
15,500
+1,000
+7% +$6.39K ﹤0.01% 4392
2024
Q3 		$71.5K Buy
14,500
+1,800
+14% +$9.4K ﹤0.01% 4412
2024
Q2 		$65.2K Sell
12,700
-3,600
-22% -$21.3K ﹤0.01% 4313
2024
Q1 		$86.6K Sell
16,300
-57,800
-78% -$413K ﹤0.01% 4264
2023
Q4 		$459K Sell
74,100
-47,400
-39% -$329K ﹤0.01% 3148
2023
Q3 		$917K Buy
121,500
+22,200
+22% +$203K ﹤0.01% 2352
2023
Q2 		$960K Buy
99,300
+92,000
+1,260% +$562K ﹤0.01% 2397
2023
Q1 		$27.6K Buy
+7,300
New +$40.7K ﹤0.01% 5304
2021
Q3 		– Sell
-200
Closed -$2K – 8498
2021
Q2 		$2K Hold
200
– – ﹤0.01% 7944
2021
Q1 		$21K Buy
+200
New +$2.25K ﹤0.01% 6743
2018
Q2 		– Sell
-30,000
Closed -$392K – 5301
2018
Q1 		$392K Buy
+30,000
New +$394K ﹤0.01% 2251
2017
Q4 		– Sell
-100
Closed -$1K – 5031
2017
Q3 		$1K Buy
+100
New +$1.32K ﹤0.01% 4705
2016
Q1 		– Sell
-100
Closed -$1K – 4766
2015
Q4 		$1K Buy
+100
New +$1.23K ﹤0.01% 4611
2015
Q3 		– Sell
-500
Closed -$7K – 5014
2015
Q2 		$7K Buy
+500
New +$7.22K ﹤0.01% 4400
2015
Q1 		– Sell
-1,600
Closed -$22K – 4977
2014
Q4 		$22K Buy
+1,600
New +$20.7K ﹤0.01% 3892
2014
Q2 		– Sell
-100
Closed -$1K – 5338
2014
Q1 		$1K Sell
100
-900
-90% -$9.87K ﹤0.01% 5068
2013
Q4 		$12K Buy
1,000
+700
+233% +$8.36K ﹤0.01% 4511
2013
Q3 		$4K Buy
+300
New +$4.19K ﹤0.01% 4821

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's LFCR Position: Q2 2025 in Review

Group One Trading sold out of Lifecore Biomedical (LFCR) in Q2 2025, closing a stake of 4,300 shares — an estimated $29K sold.

Group One Trading first reported a position in LFCR in Q2 2013 and held it in 11 quarters. The position peaked at $113K in Q3 2023. 86 funds tracked by Wall St. Rank hold LFCR as of Q2 2025.

  • Group One Trading reported no remaining Lifecore Biomedical position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 4,300 Lifecore Biomedical shares in Q2 2025, an estimated $29K.
  • Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.